What’s in it, and will it work?

US President Donald Trump has signed an executive order aimed at reducing prescription drug prices, asserting that Americans pay significantly more than patients in other countries. He claims prices could drop by up to 80%, but experts express skepticism about the effectiveness of the measures, which include pushing drug companies to match international prices and increasing direct sales to consumers. Market reactions suggest that investors do not anticipate significant immediate changes, reflecting doubts about the order’s long-term impact.